This site is intended for US Healthcare Professionals

Easy to prescribe

Starting patients on XDEMVY is as easy as 1-2-3

ePrescribe XDEMVY to an authorized pharmacy that is activated to assist

BlinkRx

Phone: 1-833-919-4942

Fax: 1-866-585-4631

12639 W Explorer Dr, Suite 100
Boise, ID 83713
NPI #: 1891461885

Carepoint Pharmacy

Phone: 1-855-237-9112

Fax: 1-855-237-9113

9 E. Commerce Drive
Schaumburg, IL 60173
NPI #: 1598013864

CenterWell Specialty Pharmacy

Phone: 1-800-486-2668

Fax: 1-877-405-7940

9843 Windisch Rd
West Chester, OH 45069
NPI #: 1942441886

CVS Specialty Pharmacy (2 locations)

Phone: 1-800-237-2767

Fax: 1-800-323-2445

800 Biermann Court Suite B
Mount Prospect, IL 60056
NPI #: 1134100134

105 Mall Boulevard
Monroeville, PA 15146
NPI #: 1043382302

Walgreens Specialty Pharmacy

Phone: 1-800-424-9002

Fax: 1-800-874-9179

41460 Haggerty Circle South
Canton, MI 48188
NPI #: 1942303110

Walmart Specialty Pharmacy

Phone: 1-877-453-4566

Fax: 1-866-537-0877

2354 Commerce Park Dr,
Orlando, FL 32819
NPI #: 1013934413

Locate a community pharmacy using the form below:

OR OR

Indicate Demodex blepharitis and provide the appropriate ICD-10 codes

For your patients with Demodex blepharitis, it is important to indicate the diagnosis and related ICD-10 diagnosis code(s), for example:
– B88.01: Infestation of Demodex mites New as of October 1, 2025
– H01.00 (Unspecified blepharitis)
– H01.001: Unspecified blepharitis right upper eyelid
– H01.002: Unspecified blepharitis right lower eyelid
– H01.003: Unspecified blepharitis right eye, unspecified eyelid
– H01.004: Unspecified blepharitis left upper eyelid
– H01.005: Unspecified blepharitis left lower eyelid
– H01.006: Unspecified blepharitis left eye, unspecified eyelid
– H01.009: Unspecified blepharitis unspecified eye, unspecified eyelid
– H01.00A: Unspecified blepharitis right eye, upper and lower eyelids
– H01.00B: Unspecified blepharitis left eye, upper and lower eyelids
– H01.8: Other specified inflammations of eyelid Updated as of October 1, 2025
Please include patient date of birth, contact phone number, prescription plan name, and pharmacy member ID
– If a prior authorization (PA) is needed, the pharmacy you selected will initiate the PA form with CoverMyMeds. The office must complete, sign, and submit the PA

It is the responsibility of the healthcare provider to clinically diagnose each patient, verify the available codes, and select the codes that accurately reflect each patient’s diagnosis. The information in this section is for informational purposes only and should not be interpreted as a guarantee of coverage or payment. Contact payers directly for the latest coverage and claims guidance. For current information on ICD-10 codes, please refer to an ICD-10-CM resource. All information is subject to change.

Set patient expectations

The pharmacy will reach out to your patient to confirm their prescription and to navigate available assistance options
- Majority of patients pay $30 or less for XDEMVY*
- Eligible, commercially insured patients may pay as little as $0*; their pharmacy can help them determine if they qualify
XDEMVY will be delivered directly to your patient’s home free of charge^†

Find Support Through Tarsus Connect

ICD-10-CM=International Classification of Diseases, 10th Revision, Clinical Modification.
*With payer coverage and available assistance options, based on eligibility requirements; see XDEMVY Savings and Access Terms and Conditions.
^†For CVS or Walgreens specialty pharmacies, patients may opt to pick up their XDEMVY prescription at their neighborhood store.

Get the info you need to send Demodex mites packing

Reference: Centers for Medicare & Medicaid Services. 2026 ICD-10-CM: October 1, 2025 UPDATE. Accessed October 30, 2025. https://www.cms.gov/medicare/coding-billing/icd-10-codes

INDICATIONS AND USAGE
XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.

IMPORTANT SAFETY INFORMATION:

WARNINGS AND PRECAUTIONS

Risk of Contamination: Do not allow the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

ADVERSE REACTIONS: The most common adverse reaction with XDEMVY was instillation site stinging and burning which was reported in 10% of patients. Other ocular adverse reactions reported in less than 2% of patients were chalazion/hordeolum and punctate keratitis.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals, Inc. at 1-888-421-4002 or the FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Please see full Prescribing Information.

Available by prescription only.